C. glabrata FKS1/CAGL0G01034g Literature Guide

Reference	Species	Other Genes Addressed
*Szekely J, et al.* (2023)** Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak. Epidemiol Infect 151:e146 CGD Papers Entry Pubmed Entry	C. albicans	\|GSC1 \|GSL1
C. glabrata	\|FKS2
C. parapsilosis	\|FKS2
*Diaz-Garcia J, et al.* (2021)** Antifungal Susceptibility Testing Identifies the Abdominal Cavity as a Source of Candida glabrata-Resistant Isolates. Antimicrob Agents Chemother 65(12):e0124921 CGD Papers Entry Pubmed Entry	C. albicans	\|ERG11 \|GSC1 \|GSL1
C. glabrata	\|ERG11 \|FKS2
*Szymankiewicz M, et al.* (2021)** Case Report: Echinocandin-Resistance Candida glabrata FKS Mutants From Patient Following Radical Cystoprostatectomy Due to Muscle-Invasive Bladder Cancer. Front Oncol 11:794235 CGD Papers Entry Pubmed Entry	C. glabrata	\|FKS2
*Saraya T, et al.* (2014)** Breakthrough invasive Candida glabrata in patients on micafungin: a novel FKS gene conversion correlated with sequential elevation of MIC. J Clin Microbiol 52(7):2709-12 CGD Papers Entry Pubmed Entry	C. glabrata	\|FKS2
*Alexander BD, et al.* (2013)** Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56(12):1724-32 CGD Papers Entry Pubmed Entry Reference LINKOUT	C. glabrata	\|FKS2
*Shields RK, et al.* (2013)** Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure. Antimicrob Agents Chemother 57(8):3528-35 CGD Papers Entry Pubmed Entry Reference LINKOUT	C. glabrata	\|FKS2
*Garcia-Effron G, et al.* (2010)** Novel FKS mutations associated with echinocandin resistance in Candida species. Antimicrob Agents Chemother 54(5):2225-7 CGD Papers Entry Pubmed Entry Reference LINKOUT	C. albicans	\|GSC1 \|GSC1 \|GSL1 \|GSL1
C. glabrata	\|FKS2
*Cleary JD, et al.* (2008)** Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob Agents Chemother 52(6):2263-5 CGD Papers Entry Pubmed Entry Reference LINKOUT	C. albicans	\|GSC1 \|GSC1

Return to CGD

CGD Copyright © 2004-2025 The Board of Trustees, Leland Stanford Junior University.
Permission to use the information contained in this database was given by the researchers/institutes who contributed or published the information. Users of the database are solely responsible for compliance with any copyright restrictions, including those applying to the author abstracts. Documents from this server are provided "AS-IS" without any warranty, expressed or implied.
To cite CGD, please use the following reference: Skrzypek MS, Binkley J, Binkley G, Miyasato SR, Simison M, Sherlock G (2017). The Candida Genome Database (CGD): incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data. Nucleic Acids Res 45 (D1); D592-D596; see How to cite CGD.